Display options
Share it on

Oncotarget. 2017 Nov 27;9(2):1563-1576. doi: 10.18632/oncotarget.22707. eCollection 2018 Jan 05.

Mitosis-specific phosphorylation of Mis18α by Aurora B kinase enhances kinetochore recruitment of polo-like kinase 1.

Oncotarget

Minkyoung Lee, Ik Soo Kim, Koog Chan Park, Jong-Seo Kim, Sung Hee Baek, Keun Il Kim

Affiliations

  1. Creative Research Initiatives Center for Chromatin Dynamics, Department of Biological Sciences, Seoul National University, Seoul 08826, South Korea.
  2. Department of Biological Sciences, Cellular Heterogeneity Research Center, Sookmyung Women's University, Seoul 04310, South Korea.
  3. Center for RNA Research, Institute for Basic Science, Department of Biological Sciences, Seoul National University, Seoul 08826, South Korea.

PMID: 29416714 PMCID: PMC5788582 DOI: 10.18632/oncotarget.22707

Abstract

Mis18α, a component of Mis18 complex comprising of Mis18α, Mis18β, and M18BP1, is known to localize at the centromere from late telophase to early G1 phase and plays a priming role in CENP-A deposition. Although its role in CENP-A deposition is well established, the other function of Mis18α remains unknown. Here, we elucidate a new function of Mis18α that is critical for the proper progression of cell cycle independent of its role in CENP-A deposition. We find that Aurora B kinase phosphorylates Mis18α during mitosis not affecting neither centromere localization of Mis18 complex nor centromere loading of CENP-A. However, the replacement of endogenous Mis18α by phosphorylation-defective mutant causes mitotic defects including micronuclei formation, chromosome misalignment, and chromosomal bridges. Together, our data demonstrate that Aurora B kinase-mediated mitotic phosphorylation of Mis18α is a crucial event for faithful cell cycle progression through the enhanced recruitment of polo-like kinase 1 to the kinetochore.

Keywords: Aurora B kinase; Mis18α; PLK1; mitosis-specific phosphorylation; polo box domain

Conflict of interest statement

CONFLICTS OF INTEREST None.

References

  1. Chromosoma. 2009 Oct;118(5):567-74 - PubMed
  2. Clin Cancer Res. 2015 Jan 15;21(2):233-9 - PubMed
  3. Nat Cell Biol. 2006 Feb;8(2):180-7 - PubMed
  4. Curr Biol. 2002 Apr 16;12(8):640-7 - PubMed
  5. Mol Cell. 2006 Nov 3;24(3):409-22 - PubMed
  6. Nat Commun. 2015 Aug 10;6:7904 - PubMed
  7. Mol Cell. 2005 Apr 29;18(3):379-91 - PubMed
  8. Cell. 2003 Sep 5;114(5):585-98 - PubMed
  9. Nat Commun. 2016 Mar 31;7:11117 - PubMed
  10. J Cell Biol. 2012 Aug 20;198(4):491-9 - PubMed
  11. J Cell Sci. 2010 Aug 15;123(Pt 16):2823-33 - PubMed
  12. Curr Biol. 2011 Nov 8;21(21):R898-903 - PubMed
  13. Mol Cancer Res. 2007 Jan;5(1):1-10 - PubMed
  14. Dev Cell. 2012 Jan 17;22(1):52-63 - PubMed
  15. Nat Commun. 2015 Dec 01;6:10036 - PubMed
  16. J Invest Dermatol. 2017 Feb;137(2):414-421 - PubMed
  17. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1984-9 - PubMed
  18. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9301-6 - PubMed
  19. Front Oncol. 2015 Oct 16;5:225 - PubMed
  20. Trends Cell Biol. 2011 Mar;21(3):133-40 - PubMed
  21. Cell. 2002 Oct 18;111(2):163-72 - PubMed
  22. Mol Biol Cell. 2006 Jan;17(1):448-59 - PubMed
  23. Dev Cell. 2012 Oct 16;23(4):745-55 - PubMed
  24. Cell. 2014 Jul 17;158(2):397-411 - PubMed
  25. Mol Cell Biol. 2015 Oct;35(20):3566-78 - PubMed
  26. Nat Protoc. 2006;1(3):1278-86 - PubMed
  27. Mol Cell. 2012 May 11;46(3):260-73 - PubMed
  28. J Mol Cell Biol. 2011 Aug;3(4):260-7 - PubMed
  29. Dev Cell. 2007 Jan;12(1):17-30 - PubMed
  30. Sci Rep. 2015 Jul 24;5:12204 - PubMed
  31. Dev Cell. 2008 May;14(5):646-59 - PubMed
  32. J Cell Biol. 2009 Feb 9;184(3):373-81 - PubMed
  33. Cell. 2003 Feb 21;112(4):407-21 - PubMed

Publication Types